Daniel Lynch - Insider Trading & Ownership

Summary
The estimated net worth of Daniel Lynch is at least $157K dollars as of July 2, 2025. Daniel Lynch is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. (TSVT) stock worth about $145K. Daniel Lynch is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $11.4K.
Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
All Insider Reports
All Insider Reports

Ownership of Daniel Lynch

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TSVT 2seventy bio, Inc. Director $145K Jun 13, 2023
BLUE bluebird bio, Inc. Director $11.4K Nov 11, 2021
SWTX SpringWorks Therapeutics, Inc. Director $0 -$12.4M -100% Jul 1, 2025
XLO Xilio Therapeutics, Inc. Director, 10%+ Owner Oct 21, 2021

Insider Transactions Reported by Daniel Lynch:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.